Our findings show that an ABI of 1.3 or more predicts for both
overall and cardiovascular mortality, and an ABI of less than 0.9 predicts for
cardiovascular mortality in CKD and haemodialysis patients. Screening
patients with chronic renal failure by means of ABI may help to identify a
high-risk group for increased mortality